Agnieszka Mlynarska-Cieslak, Anais Depaix, Ewa Grudzien-Nogalska, Pawel J Sikorski, Marcin Warminski, Megerditch Kiledjian, Jacek Jemielity, Joanna Kowalska
Journal: Organic letters 2019;20(23):7650-7655
PMID: 30479128
We report the chemical synthesis of a set of nicotinamide adenine dinucleotide (NAD) cap analogues containing chemical modifications that reduce their susceptibility to NAD-RNA-degrading enzymes. These analogues can be incorporated into transcripts in a similar way as NAD. Biochemical characterization of RNAs carrying these caps with DXO, NudC, and Nudt12 enzymes led to the identification of compounds that can be instrumental in unraveling so far unaddressed biological aspects of NAD-RNAs.
Other Literature Sources:
Miscellaneous:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.